Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001081448 | SCV001121788 | benign | Peroxisome biogenesis disorder, complementation group 7 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001099330 | SCV001255777 | benign | Peroxisome biogenesis disorder 6A (Zellweger) | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Mayo Clinic Laboratories, |
RCV000676042 | SCV000801776 | likely benign | not provided | 2017-07-26 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001273138 | SCV001455743 | benign | Zellweger spectrum disorders | 2020-09-16 | no assertion criteria provided | clinical testing |